Introduction: Splenic tumors are rare and often a source of misdiagnosis. The differential diagnosis of splenic metastasis includes benign and malignant etiologies. Visceral metastases in patients with ovarian cancer represent hematogenous spread of the disease[1].As capsular involvement is more common[2]. Cystic splenic metastasis are even more unusual. Splenectomies for ovarian cancer are usually performed for cytoreduction. Case Report: We present a rare case of splenic cystic metastasis from ovarian cystadenocarcinoma treated with surgery with neoadjuvant chemotherapy. The evolution was characterized by the death of the patient 06months after her surgery from a pulmonary embolism. Conclusion: In summary, splenic metastasis is a relatively rare event. Often asymptomatic, it is usually detected as part of a work up exams of primary cancers, among them ovarian cancer which is highly associated with secondary splenic spread. The work up include imaging studies such as ultrasound and CT scan as well as measurement of CA-125, which often correlated to prognosis. Splenectomy is the treatment of choice. However, it is not done, as splenic metastasis is indicative of advanced disease. In case of a primary ovarian cancer it is often associated to peritoneal carcinomatosis. This case highlights the importance of intraprenchymal cystic splenic metastasis in case of ovarian cystadenocarcinoma as part of the wide range of splenic masses.